Learn about depression, its symptoms, causes, and treatment options. Get trusted information from NAMI to better understand ...

Biohaven didn't receive the clinical readout it was hoping for over the festive period. | As the biopharma wound down for the ...

Gilgamesh Pharma, a clinical-stage neuroscience company focused on transforming psychiatric treatment, today announced positive topline results from its Phase 2a study of blixeprodil (GM-1020).

Depression, one of the most prevalent mental health disorders worldwide, is characterized by persistent feelings of sadness, ...

Biohaven Ltd. recently reported that its Phase 2 proof-of-concept trial of BHV-7000 for major depressive disorder failed to meet the primary MADRS endpoint over six weeks versus placebo, although the ...

Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

Patients with first-episode MDD showed lower effective and functional connectivity between the anterior cingulate cortex and frontal regions.

Taking probiotics and magnesium together is considered safe and may help with mood and the gut microbiome. It's not ...